全文获取类型
收费全文 | 109822篇 |
免费 | 6644篇 |
国内免费 | 2090篇 |
专业分类
耳鼻咽喉 | 620篇 |
儿科学 | 2213篇 |
妇产科学 | 1428篇 |
基础医学 | 8237篇 |
口腔科学 | 2533篇 |
临床医学 | 9945篇 |
内科学 | 20678篇 |
皮肤病学 | 926篇 |
神经病学 | 6547篇 |
特种医学 | 2191篇 |
外国民族医学 | 12篇 |
外科学 | 12818篇 |
综合类 | 14855篇 |
现状与发展 | 1篇 |
一般理论 | 5篇 |
预防医学 | 10537篇 |
眼科学 | 1322篇 |
药学 | 9959篇 |
159篇 | |
中国医学 | 9920篇 |
肿瘤学 | 3650篇 |
出版年
2023年 | 1783篇 |
2022年 | 2660篇 |
2021年 | 4286篇 |
2020年 | 3824篇 |
2019年 | 5709篇 |
2018年 | 4810篇 |
2017年 | 4121篇 |
2016年 | 3180篇 |
2015年 | 2836篇 |
2014年 | 6061篇 |
2013年 | 5879篇 |
2012年 | 5278篇 |
2011年 | 6226篇 |
2010年 | 5330篇 |
2009年 | 4268篇 |
2008年 | 4022篇 |
2007年 | 4084篇 |
2006年 | 3615篇 |
2005年 | 3056篇 |
2004年 | 2459篇 |
2003年 | 2184篇 |
2002年 | 1625篇 |
2001年 | 1397篇 |
2000年 | 1120篇 |
1999年 | 983篇 |
1998年 | 759篇 |
1997年 | 681篇 |
1996年 | 576篇 |
1995年 | 675篇 |
1994年 | 646篇 |
1993年 | 517篇 |
1992年 | 512篇 |
1991年 | 431篇 |
1990年 | 351篇 |
1989年 | 341篇 |
1988年 | 333篇 |
1987年 | 281篇 |
1985年 | 1875篇 |
1984年 | 2860篇 |
1983年 | 2581篇 |
1982年 | 2047篇 |
1981年 | 2135篇 |
1980年 | 1786篇 |
1979年 | 1589篇 |
1978年 | 1360篇 |
1977年 | 873篇 |
1976年 | 1255篇 |
1975年 | 1053篇 |
1974年 | 884篇 |
1973年 | 830篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
《Vaccine》2022,40(12):1855-1863
Renewed COVID-19 outbreaks, stemming from the highly infectious Delta and Omicron variants, prompted rising fears of a ‘pandemic among the unvaccinated’. To address this prevalent vaccination crisis, media framing communication strategies can amplify the scientific evidence on COVID-19 vaccines to reach diverse geographic and socio-economic communities. The critical role of media framing strategies to engage and encourage large populations regarding vaccine acceptance has been rarely studied, despite growing evidence on vaccine hesitancy. The present study used a multi-method approach (i.e., content analysis and quasi-experiments) that unpacked the framing practices employed by the mainstream media in Pakistan. The findings of the content analysis revealed that the media extensively used uncertainty, conflict, consequences, and action rather than new evidence and reassurance frames in its COVID-19 related campaigns. In a series of quasi-experiments involving 720 participants, we manipulated these six frames of COVID-19 related news coverage (i.e., uncertainty, conflict, consequences, action, new evidence, and reassurance) to investigate the underlying mechanism that influences vaccine acceptance. The findings established that the message-consistent effects of media frames manifesting fear (e.g., consequence and uncertainty) and action cues made receivers more supportive of vaccination. The present study findings theoretically address the calls for a more inclusive “community-health reporting model”, besides offering new evidence on the media framing strategies to deliver more targeted, meaningful, and effective campaigns to raise public acceptance for COVID-19 vaccines. 相似文献
22.
《Vaccine》2022,40(6):904-911
BackgroundGSK initiated a Pregnancy Registry in the United States (US) for the reduced-antigen-content tetanus-diphtheria-acellular pertussis (Tdap; Boostrix, GSK) vaccine with the aim to detect and describe pregnancy outcomes in women vaccinated with Boostrix 28 days before estimated conception or during pregnancy.MethodsVoluntary reports of pregnancy exposure to Boostrix received from spontaneous and post-marketing surveillance sources in the US were assessed. Reports were classified as prospective or retrospective based on the knowledge of pregnancy outcomes at the time of reporting. For completeness, reports of exposure to Boostrix or to the Tdap-inactivated poliovirus vaccine (Boostrix-IPV, GSK) reported to the global safety database from countries outside the US were also evaluated.ResultsFrom May 2005 to August 2019, 1517 (1455 prospective and 62 retrospective) pregnancy reports were received in the Boostrix US Pregnancy Registry. Of the prospective reports, 250 had known outcomes: 244 live infants with no apparent birth defects (BDs), three live infants with BDs, and three spontaneous abortions with no apparent BDs. Of the retrospective reports, 55 had known outcomes: 33 live infants with no apparent BDs, 16 live infants with BDs, one spontaneous abortion with no apparent BDs, four stillbirths with no apparent BDs, and one stillbirth with BDs. Cumulatively, 1321 pregnancy reports (1006 for Boostrix; 315 for Boostrix-IPV) were received from countries outside the US. Of these, 163 prospective reports and 551 retrospective reports had known outcomes. Results were in line with those from the Boostrix US Pregnancy Registry.ConclusionsData currently available from the Boostrix US Pregnancy Registry and from countries outside the US suggested that exposure to Boostrix or Boostrix-IPV during pregnancy does not raise safety concerns related to adverse pregnancy outcomes or BDs. 相似文献
23.
目的 了解我国老年人中医证候分布特征,为中医药辨治老年人提供参考依据。方法 系统检索中国知识基础设施(CNKI)、中文科技期刊数据库(CCD)、万方数据资源系统数据库(CSPD),纳入研究对象为老年人的临床流行病学调查研究文献,对其调查目的、调查疾病及调查结果等进行描述统计。结果 ①最终纳入168篇文献,其中2010至2020年之间发表138篇(82.14%);调查地区涵盖全国28个省市自治区,共纳入43948例老年人,累计覆盖340个研究中心;②主要研究结果显示,老年人中医证候阴虚阳亢证(10.05%)>血瘀证(9.5%)>痰浊(湿)证(8.91%)>阴阳两虚证(4.98%)>痰瘀互结证(4.96%);单元证分布阴虚证(14.70%)>痰证(11.22%)>气虚证(7.15%)>肾虚证(4.72%)>血瘀证(4.18%);涉及病变脏腑肾>肝>脾>肺>心。结论 根据统计结果,可以看出老年人证候分布虚证多于实证,虚证中又以阴虚证、气虚证最为多见,实证常见血瘀证、痰浊(湿)证等,且多见痰瘀互结证;老年人五脏皆损,其中又以肾、肝、脾功能失调最为突出。 相似文献
24.
25.
26.
在当前国际制药技术出现重大创新和变革、药品研发技术信息化和数字化程度不断发展,以及新型冠状病毒肺炎(COVID-19)疫情大流行的背景下,欧盟委员会为满足未竟临床需求、激励行业创新、增强监管系统应变能力、巩固欧盟药品监管体系国际地位,于2020年底发布了《欧洲药物战略》(Pharmaceutical Strategy for Europe,PSE)。PSE被视为欧洲未来5年卫生政策的“基石”,对欧洲制药领域发展和管理具有重要指导意义。通过对PSE制定背景及发展战略目标、具体举措等内容进行梳理分析,并结合中国COVID-19疫情防控与行业发展、药品科学监管与鼓励创新等实际工作提出政策建议。 相似文献
27.
28.
29.
30.
《Journal of vascular and interventional radiology : JVIR》2022,33(12):1476-1484.e2
PurposeTo evaluate temporal trends, practice variation, and associated outcomes with the use of intravascular ultrasound (US) during deep venous stent placement among Medicare beneficiaries.Materials and MethodsAll lower extremity deep venous stent placement procedures performed between January 1, 2017, and December 31, 2019 among Medicare beneficiaries were included. Temporal trends in intravascular US use were stratified by procedural setting and physician specialty. The primary outcome was a composite of 12-month all-cause mortality, all-cause hospitalization, or repeat target vessel intervention. The secondary outcome was a composite of 12-month stent thrombosis, embolization, or restenosis.ResultsAmong the 20,984 deep venous interventions performed during the study period, 15,184 (72.4%) utilized intravascular US. Moderate growth in intravascular US use was observed during the study period in all clinical settings. There was a variation in the use of intravascular US among all operators (median, 77.3% of cases; interquartile range, 20.0%–99.2%). In weighted analyses, intravascular US use during deep venous stent placement was associated with a lower risk of both the primary (adjusted hazard ratio, 0.72; 95% confidence interval [CI], 0.69–0.76; P < .001) and secondary (adjusted hazard ratio, 0.32; 95% CI, 0.27–0.39; P < .001) composite end points.ConclusionsIntravascular US is frequently used during deep venous stent placement among Medicare beneficiaries, with further increase in use from 2017 to 2019. The utilization of intravascular US as part of a procedural strategy was associated with a lower cumulative incidence of adverse outcomes after the procedure, including venous stent thrombosis and embolization. 相似文献